What Cell Line Services Does BiologicsCorp Offer?
Updated
BiologicsCorp offers three cell line service categories listed on its site: cell lines for research, cell lines for production, and gene knockout cell lines. The company also describes stable cell line construction as a service area, positioned alongside its recombinant protein and antibody production work. If you need a cell line built or modified as part of a protein or antibody project, these are the relevant service lines to look at. The site does not list specific cell line names, turnaround times, or prices, so those details would need to come from a direct quote.
The three cell line service categories
| Service | Stated purpose |
|---|---|
| Cell Line for Research | Cell line development intended for research use |
| Cell Line for Production | Cell line development intended for production use |
| Gene Knockout Cell Line | Generation of cell lines with a gene knocked out |
The distinction between research and production cell lines matters for how you plan a project. A research-use line is typically the fit when you need material for experiments, assay development, or early characterization. A production-use line is the fit when the line is meant to carry forward into a manufacturing or scale-up context. Because the site does not spell out the exact criteria it applies to each category, treat the split as a signal of intent rather than a fixed technical specification, and confirm the requirements for your specific application when you request a quote.
Gene knockout cell lines are a separate offering: instead of expressing a protein, the goal is to remove or disable a specific gene. This is useful when you want to study what a gene does by observing what changes in its absence, or when you need a background line that does not express a particular protein.
Stable cell line construction
BiologicsCorp lists stable cell line construction as one of its service areas, described as backed by expertise and research experience in the field. A stable cell line is one where the introduced genetic material is maintained across cell divisions, rather than being expressed only transiently. That makes stable lines the usual choice when you need a consistent supply of the same protein or antibody over time, rather than a single batch.
The site also notes, under its mammalian expression system, that it offers transient or stable cell line generation and development tailored to the client's needs. So if your project sits within mammalian expression, the transient-versus-stable decision is part of the service conversation rather than something you have to solve beforehand.
How cell line services connect to protein and antibody production
These services are not standalone. They sit inside a broader workflow the company describes:
- Recombinant protein expression across mammalian, bacterial, yeast, and insect systems.
- Recombinant antibody production, including IgG, IgE, and IgD, plus formats such as single-chain antibody, Fab fragment, and chimeric antibody, and Fc fusion protein expression.
- Stable cell line construction, which supports the production side of the above.
The practical implication: if you are commissioning a recombinant protein or antibody and expect to need it repeatedly, a stable production cell line is the piece that makes repeated supply feasible. If you only need a one-time batch, a transient approach may be sufficient, and the cell line service may be less central to your project.
What to confirm before engaging
The site does not publish which specific cell lines it works with, how long construction takes, or what it charges. Before committing, ask:
- Which expression system fits your target protein or antibody, and whether the cell line service applies to that system.
- Whether your project needs a research-use or production-use line, and what the company requires to qualify a line for production.
- For knockout work, which gene and which background line, since knockout feasibility depends heavily on both.
- Whether you need transient expression only, or a stable line, based on how much material you will need over time.
BiologicsCorp advertises competitive pricing on its bacterial expression service (stated as 30% below the industrial average) with a "no delivery, no charge" term, but no equivalent pricing signal is given for cell line services, so do not assume the same terms apply. Request a quote for the specific service and system you need.